Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin

被引:73
作者
Varani, J
Hattori, Y
Chi, Y
Schmidt, T
Perone, P
Zeigler, ME
Fader, DJ
Johnson, TM
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA
关键词
interstitial collagenase; collagenase-3; tissue inhibitoral metalloproteinase invasion; fibroblast; epithelial cells; endothelial cells;
D O I
10.1054/bjoc.1999.0978
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue from 54 histologically-identified basal cell carcinomas of the skin was obtained at surgery and assayed using a combination of functional and immunochemical procedures for matrix metalloproteinases (MMPs) with collagenolytic activity and for MMPs with gelatinolytic activity. Collagenolytic enzymes included MMP-1 (interstitial collagenase), MMP-8 (neutrophil collagenase) and MMP-13 (collagenase-3). Gelatinolytic enzymes included MMP-2 (72-kDa gelatinase A/type IV collagenase) and MMP-9 (92-kDa gelatinase B/type IV collagenase). Inhibitors of MMP activity including tissue inhibitor of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) were also assessed. All three collagenases and both gelatinases were detected immunochemically. MMP-1 appeared to be responsible for most of the functional collagenolytic activity while gelatinolytic activity reflected both MMP-2 and MMP-9. MMP inhibitor activity was also present, and appeared, based on immunochemical procedures, to reflect the presence of TIMP-1 but not TIMP-2. As a group, tumours identified as having aggressive-growth histologic patterns were not distinguishable from basal cell carcinomas with less aggressive-growth histologic patterns. In normal skin, the same MMPs were detected by immunochemical means. However, only low to undetectable levels of collagenolytic and gelatinolytic activities were present. In contrast, MMP inhibitor activity was comparable to that seen in tumour tissue. in previous studies we have shown that exposure of normal skin to epidermal growth factor in organ culture induces MMP up-regulation and activation. This treatment concomitantly induces stromal invasion by the epithelium (Varani et al (1995) Am J Pathol 146. 210-217; Zeigler et al (1996b) Invasion Metastasis 16:11-18). Taken together with these previous data, the present findings allow us to conclude that the same profile of MMP/MMP inhibitors that is associated with stromal invasion in the organ culture model is expressed endogenously in basal cell carcinomas of skin. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:657 / 665
页数:9
相关论文
共 55 条
[31]   IN-VIVO SUPPRESSION OF IMMUNE COMPLEX-INDUCED ALVEOLITIS BY SECRETORY LEUKOPROTEINASE INHIBITOR AND TISSUE INHIBITOR OF METALLOPROTEINASES-2 [J].
MULLIGAN, MS ;
DESROCHERS, PE ;
CHINNAIYAN, AM ;
GIBBS, DF ;
VARANI, J ;
JOHNSON, KJ ;
WEISS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11523-11527
[32]  
POLETTE M, 1991, INVAS METAST, V11, P76
[33]  
PYKE C, 1992, CANCER RES, V52, P1336
[34]  
REICH R, 1988, CANCER RES, V48, P3307
[35]  
Rosenthal EL, 1998, CANCER RES, V58, P5221
[36]   CELL-MATRIX INTERACTIONS MODULATE INTERSTITIAL COLLAGENASE EXPRESSION BY HUMAN KERATINOCYTES ACTIVELY INVOLVED IN WOUND-HEALING [J].
SAARIALHOKERE, UK ;
KOVACS, SO ;
PENTLAND, AP ;
OLERUD, JE ;
WELGUS, HG ;
PARKS, WC .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2858-2866
[37]   MORPHEAFORM BASAL-CELL EPITHELIOMAS - A STUDY OF SUB-CLINICAL EXTENSIONS IN A SERIES OF 51 CASES [J].
SALASCHE, SJ ;
AMONETTE, RA .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1981, 7 (05) :387-394
[38]   ACTIVATION OF THE 92-KDA GELATINASE BY STROMELYSIN AND 4-AMINOPHENYLMERCURIC ACETATE - DIFFERENTIAL PROCESSING AND STABILIZATION OF THE CARBOXYL-TERMINAL DOMAIN BY TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP) [J].
SHAPIRO, SD ;
FLISZAR, CJ ;
BROEKELMANN, TJ ;
MECHAM, RP ;
SENIOR, RM ;
WELGUS, HG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :6351-6356
[39]  
SHIMA I, 1992, CANCER, V70, P2747, DOI 10.1002/1097-0142(19921215)70:12<2747::AID-CNCR2820701204>3.0.CO
[40]  
2-5